183 related articles for article (PubMed ID: 30122941)
1. Cancer/testis antigens (CTAs) expression in resected lung cancer.
Jin S; Cao S; Li J; Meng Q; Wang C; Yao L; Lang Y; Cao J; Shen J; Pan B; Hu J; Yu Y
Onco Targets Ther; 2018; 11():4491-4499. PubMed ID: 30122941
[TBL] [Abstract][Full Text] [Related]
2. Predictive and prognostic effect of CD133 and cancer-testis antigens in stage Ib-IIIA non-small cell lung cancer.
Su C; Xu Y; Li X; Ren S; Zhao C; Hou L; Ye Z; Zhou C
Int J Clin Exp Pathol; 2015; 8(5):5509-18. PubMed ID: 26191258
[TBL] [Abstract][Full Text] [Related]
3. Early gastric cancer frequently has high expression of KK-LC-1, a cancer-testis antigen.
Futawatari N; Fukuyama T; Yamamura R; Shida A; Takahashi Y; Nishi Y; Ichiki Y; Kobayashi N; Yamazaki H; Watanabe M
World J Gastroenterol; 2017 Dec; 23(46):8200-8206. PubMed ID: 29290656
[TBL] [Abstract][Full Text] [Related]
4. Expression of four cancer-testis antigens in TNBC indicating potential universal immunotherapeutic targets.
Xiao J; Huang F; Li L; Zhang L; Xie L; Liu B
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15003-15011. PubMed ID: 37610673
[TBL] [Abstract][Full Text] [Related]
5. Expression of cancer-testis antigens MAGE-A3/6 and NY-ESO-1 in non-small-cell lung carcinomas and their relationship with immune cell infiltration.
Kim SH; Lee S; Lee CH; Lee MK; Kim YD; Shin DH; Choi KU; Kim JY; Park DY; Sol MY
Lung; 2009; 187(6):401-11. PubMed ID: 19795170
[TBL] [Abstract][Full Text] [Related]
6. Establishment of cancer/testis antigen profiling based on clinicopathological characteristics in resected pathological stage III non-small cell lung cancer.
Jin S; Cao S; Grigorev A; Li J; Meng Q; Wang C; Feng M; Hu J; Jiang F; Yu Y
Cancer Manag Res; 2018; 10():2031-2046. PubMed ID: 30038519
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Cancer/Testis Antigens as Prognostic Markers of Ovarian Cancer.
Vlasenkova R; Konysheva D; Nurgalieva A; Kiyamova R
Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835834
[TBL] [Abstract][Full Text] [Related]
8. Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma.
Gjerstorff MF; Pøhl M; Olsen KE; Ditzel HJ
BMC Cancer; 2013 Oct; 13():466. PubMed ID: 24103781
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigen expression in synovial sarcoma: NY-ESO-1, PRAME, MAGEA4, and MAGEA1.
Iura K; Maekawa A; Kohashi K; Ishii T; Bekki H; Otsuka H; Yamada Y; Yamamoto H; Harimaya K; Iwamoto Y; Oda Y
Hum Pathol; 2017 Mar; 61():130-139. PubMed ID: 27993576
[TBL] [Abstract][Full Text] [Related]
10. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer.
Shigematsu Y; Hanagiri T; Shiota H; Kuroda K; Baba T; Mizukami M; So T; Ichiki Y; Yasuda M; So T; Takenoyama M; Yasumoto K
Lung Cancer; 2010 Apr; 68(1):105-10. PubMed ID: 19545928
[TBL] [Abstract][Full Text] [Related]
12. Frequent High Expression of Kita-Kyushu Lung Cancer Antigen-1 (KK-LC-1) in Gastric Cancer.
Shida A; Futawatari N; Fukuyama T; Ichiki Y; Takahashi Y; Nishi Y; Kobayashi N; Yamazaki H; Watanabe M
Anticancer Res; 2015 Jun; 35(6):3575-9. PubMed ID: 26026129
[TBL] [Abstract][Full Text] [Related]
13. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
Grah J; Samija M; Juretić A; Sarcević B; Sobat H
Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
[TBL] [Abstract][Full Text] [Related]
14. The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.
John T; Starmans MH; Chen YT; Russell PA; Barnett SA; White SC; Mitchell PL; Walkiewicz M; Azad A; Lambin P; Tsao MS; Deb S; Altorki N; Wright G; Knight S; Boutros PC; Cebon JS
PLoS One; 2013; 8(7):e67876. PubMed ID: 23935846
[TBL] [Abstract][Full Text] [Related]
15. Expressions of melanoma-associated antigen A1 as a prognostic factor in Chinese patients with resectable oesophageal squamous cell carcinoma.
Yu Y; Huang C; Li Z; Zhao F; Zhou Y; Li J; Zhu C; Li Q; Zhuang Y; Xu J; Luo J; Chen L; Wang W
Interact Cardiovasc Thorac Surg; 2019 Oct; 29(4):510-516. PubMed ID: 31169876
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of EFCC1 and its prognostic value in lung adenocarcinoma.
Xia L; Zhu Y; Zhang C; Deng S; Deng Y; Yang Z; Mei J; Liu L
Ann Transl Med; 2019 Nov; 7(22):672. PubMed ID: 31930073
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of cancer-testis antigens (CTA) in intrahepatic cholagiocarcinoma.
Zhou JX; Li Y; Chen SX; Deng AM
J Exp Clin Cancer Res; 2011 Jan; 30(1):2. PubMed ID: 21211023
[TBL] [Abstract][Full Text] [Related]
18. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
19. Detection of autoantibodies against cancer-testis antigens in non-small cell lung cancer.
Djureinovic D; Dodig-Crnković T; Hellström C; Holgersson G; Bergqvist M; Mattsson JSM; Pontén F; Ståhle E; Schwenk JM; Micke P
Lung Cancer; 2018 Nov; 125():157-163. PubMed ID: 30429015
[TBL] [Abstract][Full Text] [Related]
20. Expression and clinical significance of the Trop-2 gene in advanced non-small cell lung carcinoma.
Jiang A; Gao X; Zhang D; Zhang L; Lu H
Oncol Lett; 2013 Aug; 6(2):375-380. PubMed ID: 24137332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
